@u-labu.bsky.social
@lobularbca.bsky.socialOn Oct. 4, the Lobular Breast Cancer Awareness Tour stopped at Ohio State University (OSU) for a lab tour with LBCA SAB member Dr. Daniel Stover, offering a closer look at ILC research underway at OSU. Next, we connected with #ILC advocates at a group meet-up and dinner. Stay tuned for what's next!
@dianeheditsian.bsky.sociallobularbreastcancer.org/lbca-research-grantee-interview-exploring-what-drives-ilc-metastasis/ #bcsm, #lobularbreastcan #ILC, #lobular, #ILCAwareness, #learnaboutlobular
Christina Curtis & Deborah Rohmer: Important new ILC research and "how to's of good advocacy".
@lobularbca.bsky.socialLBCA is thankful to Amanda Peet for continuing to share her journey with lobular breast cancer and bringing awareness to the challenges of ILC: www.today.com/video/amanda...
#LobularBreastCancer #invasivelobularcarcinoma #ILC #ilcawareness #lobularbreastcancerawareness #BreastCancerAwarenessMonth
@lobularbca.bsky.socialThe Lobular Breast Cancer Awareness Tour launched from San Francisco, CA on Saturday and is headed across the US stopping in over 15 cities. Meet us at a stop on the road! Check out the full itinerary: lobularbreastcancer.org/awareness-day/
#ILCAwarenessTour #LobularBreastCancer #ILC
@lobularbca.bsky.socialLobular Breast Cancer survivor Gladys Bettis, or “Mama Bus” mother of NFL Hall of Famer “The Bus” Jerome Bettis agrees it's Time To Talk About Lobular Breast Cancer! Learn more lobularbreastcancer.org/awareness-day/
#lobularbreastcancer #invasivelobularcarcinoma #ILC #ilcawarenesstour
@doublewhammied.bsky.social"Patient advocates are research partners. We can provide the scientific expertise; they provide the lived experience. Patients are really the ones responsible for making #ILC visible to the research community." - Dr. Mo Rimawi
Hear hear!!!
#ILCSymposium #lobmob @lobularbca.bsky.social
@doublewhammied.bsky.socialDr. Karen van Baelen looked at modifiable risk factors in #ILC recurrence. Physical activity once again shown to be beneficial for #breastcancer patients! #ILCSymposium #lobmob #bcsm #exerciseismedicine
@doublewhammied.bsky.socialDr. Rachel Jankowitz talks about #lobular #breastcancer in premenopausal patients. Stays say 80-85% of ILC pts are postmenopausal; 10-15% are premenopausal. BUT at UCSF, 28% of #ILC pts were premenopausal; at Penn, 35% of ILC pts were premenopausal. #ILCSymposium @lobularbca.bsky.social #lobmob
@doublewhammied.bsky.socialCan artificial intelligence improve subtyping of #lobular #breastcancer? A look at subtypes & the possibility of reclassifying #ILC morphology. #ILCSymposium @lobularbca.bsky.social @lobularbcuk.bsky.social
@doublewhammied.bsky.socialThere's been "tremendous progress" in the creation of scientific models of #ILC for research -- always good for patients to hear! And more coming, per Dr. Adrien Lee. #ILCSymposium #BCSM @lobularbca.bsky.social @elbcc-2018.bsky.social @lobularbcuk.bsky.social
@doublewhammied.bsky.socialILC #breastcancer lacks models. Dr. Adrien Lee talked about the development of #ILC patient derived organoids and cell lines, a project launched w/help from @fredhutch.org #lobular #BC advocate Leigh Pate, founder of @lobularbca.bsky.social, who died in 2022. #ILCSymposium. RIP and well done, Leigh!
@lobularbca.bsky.socialLBCA spoke with Dr. Curtis of Stanford University and #ILC research advocate Deborah Romer about research exploring what drives ILC recurrence and metastasis.
Watch the interview: tinyurl.com/What-Drives-...
@stephanie-baert.bsky.social#JORF - Indice des loyers commerciaux (ILC) - 2ème trimestre de 2026
#Indice #Loyers #ILC
www.legifrance.gouv.fr/jorf/id/JORF...
@lobularbca.bsky.socialDr. Stephen Purdy of the University of Pittsburgh has received an AACR/LBCA Fellowship Award for research that will contribute to a deeper understanding of the unique biology of ILC. Learn more about LBCA’s #ILC research grants: lobularbreastcancer.org/our-ilc-rese...
@dfcibreastonc.bsky.socialBreast oncologist Kristina Fanucci, MD, MHS, shares information about #InvasiveLobularCarcinoma (ILC) #BreastCancer, focusing on its characteristics and current advances in research that are leading to treatments designed specifically for patients with #ILC breast cancer.
@lobularbca.bsky.socialThe 2026 LBCA Lobular Breast Cancer Awareness Tour hits the road Sept. 26th. Check out the updated itinerary and event details for each stop across more than 15 cities:https://lobularbreastcancer.org/awareness-day/ #ilcawarenesstour #ILC #lobularbreastcancer #invasivelobularcarcinoma
@lobularbca.bsky.socialLBCA has earned a Four-Star Charity designation from Charity Navigator! ⭐ ⭐ ⭐ ⭐ This recognition reflects our commitment to accountability, transparency, and making every donation count in advancing #ILC research, education, and advocacy. Learn more: www.charitynavigator.org/ein/862260246
@lobularbca.bsky.socialLBCA recently launched a newly reorganized website! Informed by community feedback, the updated site makes it easier to navigate and find trusted, ILC-specific information and resources. Explore the website: lobularbreastcancer.org
@lobularbca.bsky.socialLBCA’s #ILC Training for Advocates is now available on demand! Developed with ILC researchers and clinicians, the curriculum covers ILC biology, treatment, imaging and surveillance. Explore the curriculum and watch the videos: lobularbreastcancer.org/ilc-training...